Expanding Ultrashort Laser Pulse Technology to Novel Applications

This inventive concept leverages the core technology of ultrashort laser pulses to pioneer new applications in chronic pain treatment, neurological disorders, skin conditions, cancer, and hearing loss, offering unprecedented solutions to pressing healthcare challenges.

The original patent focused on treating glaucoma using ultrashort laser pulses. However, the technology's potential extends far beyond ophthalmic surgery. The present inventive concept addresses the limitations of existing treatments in various fields by harnessing the precision and efficacy of ultrashort laser pulses to target specific tissue and cells, providing innovative solutions to diverse healthcare problems.

The inventive concept comprises a system or device that incorporates a laser pulse generator, a delivery system (fiberoptic or handheld), and a control system. The laser pulse generator produces ultrashort laser pulses, which are directed to a target region in the patient's body via the delivery system. The control system regulates the laser pulse parameters to selectively ablate tissue or cells, achieving the desired therapeutic effect. For chronic pain treatment, the target region is the nervous system. For neurological disorders, the target region is the brain. For skin conditions, the target region is the skin. For cancer treatment, the target region is the tumor. For hearing loss treatment, the target region is the cochlea.

The novelty of this inventive concept lies in the application of ultrashort laser pulse technology to entirely new fields, leveraging its precision and efficacy to address unmet needs in healthcare. The inventive step resides in the recognition of the technology's potential beyond ophthalmic surgery and the development of novel systems, devices, and methods to harness this potential.

Alternative embodiments may include varying the laser pulse parameters, such as wavelength, duration, and intensity, to optimize treatment outcomes. Other variations may involve using different delivery systems, such as endoscopic or robotic-assisted systems, to access target regions. Additionally, the inventive concept could be adapted for use in veterinary medicine or other fields where precise tissue ablation is beneficial.

This inventive concept has far-reaching commercial potential, with applications in multiple healthcare industries, including pain management, neurology, dermatology, oncology, and otolaryngology. The market for these applications is substantial, with millions of people worldwide suffering from chronic pain, neurological disorders, skin conditions, cancer, and hearing loss. The innovative solutions offered by this inventive concept could capture a significant share of these markets, providing a substantial revenue stream for companies that develop and commercialize these technologies.